We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Grants Bio-Rad License to Kreutzer-Limmer Patents for the RNAi Research Products Market

News   Mar 30, 2007

 
Alnylam Grants Bio-Rad License to Kreutzer-Limmer Patents for the RNAi Research Products Market
 
 
 

RELATED ARTICLES

Why Not Catching Enough Zzz’s Is Bad for Your Heart

News

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.

READ MORE

Timing Is Key in Cell Protein Production

News

Scientists at the University of Sheffield have discovered how genes create proteins in research which could aid the development of treatments for human diseases.

READ MORE

Stem Cell Resilience Model of Oculomotor Neurons a Boost for ALS Research

News

A stem cell-based model of neuron resilience has been developed to help identify genes contributing to resilience, with the possibility of leveraging the findings in gene therapy to strengthen sensitive motor neurons.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE